Susanne E. Churchill, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 24 | 2019 | 4467 | 0.680 |
Why?
|
| Inflammatory Bowel Diseases | 12 | 2019 | 2428 | 0.500 |
Why?
|
| Personal Autonomy | 1 | 2016 | 298 | 0.470 |
Why?
|
| Colitis, Ulcerative | 8 | 2019 | 1911 | 0.430 |
Why?
|
| Crohn Disease | 8 | 2019 | 2304 | 0.410 |
Why?
|
| Natural Language Processing | 10 | 2019 | 1041 | 0.390 |
Why?
|
| Health Education | 1 | 2016 | 1056 | 0.340 |
Why?
|
| Algorithms | 16 | 2021 | 13869 | 0.340 |
Why?
|
| Information Storage and Retrieval | 6 | 2019 | 824 | 0.310 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2012 | 607 | 0.290 |
Why?
|
| Arthritis, Rheumatoid | 9 | 2015 | 3712 | 0.250 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 3965 | 0.230 |
Why?
|
| Antidepressive Agents | 5 | 2016 | 2837 | 0.210 |
Why?
|
| Vitamin D | 4 | 2015 | 3222 | 0.180 |
Why?
|
| Medical Record Linkage | 1 | 2021 | 284 | 0.180 |
Why?
|
| Depressive Disorder, Major | 5 | 2014 | 4635 | 0.160 |
Why?
|
| Depressive Disorder | 4 | 2016 | 3744 | 0.150 |
Why?
|
| Phenotype | 9 | 2019 | 16361 | 0.150 |
Why?
|
| Clostridium Infections | 2 | 2014 | 548 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2016 | 4422 | 0.130 |
Why?
|
| Autoantibodies | 3 | 2013 | 2037 | 0.130 |
Why?
|
| Hospitalization | 5 | 2014 | 10259 | 0.120 |
Why?
|
| Suicide, Attempted | 1 | 2023 | 1218 | 0.120 |
Why?
|
| Cohort Studies | 18 | 2016 | 40545 | 0.120 |
Why?
|
| Gastrointestinal Agents | 2 | 2016 | 494 | 0.120 |
Why?
|
| Vitamin D Deficiency | 2 | 2013 | 1342 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 944 | 0.120 |
Why?
|
| Blood Sedimentation | 1 | 2014 | 231 | 0.110 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2016 | 2407 | 0.110 |
Why?
|
| Pregnancy, Animal | 3 | 1982 | 134 | 0.110 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2014 | 434 | 0.110 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2014 | 160 | 0.100 |
Why?
|
| Confidentiality | 2 | 2019 | 613 | 0.100 |
Why?
|
| Adult | 32 | 2016 | 213889 | 0.100 |
Why?
|
| Data Mining | 1 | 2017 | 537 | 0.100 |
Why?
|
| Sex Ratio | 1 | 2012 | 109 | 0.100 |
Why?
|
| Systems Integration | 2 | 2011 | 440 | 0.100 |
Why?
|
| Biomedical Research | 3 | 2013 | 3308 | 0.100 |
Why?
|
| Antibodies, Antinuclear | 1 | 2013 | 326 | 0.100 |
Why?
|
| Anxiety Disorders | 2 | 2013 | 2684 | 0.100 |
Why?
|
| Software | 4 | 2014 | 4440 | 0.100 |
Why?
|
| Sjogren's Syndrome | 1 | 2013 | 234 | 0.100 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2014 | 503 | 0.100 |
Why?
|
| Colorectal Neoplasms | 3 | 2016 | 6773 | 0.090 |
Why?
|
| Parturition | 1 | 2014 | 441 | 0.090 |
Why?
|
| Male | 39 | 2016 | 349776 | 0.090 |
Why?
|
| New England | 4 | 2014 | 1022 | 0.090 |
Why?
|
| Female | 42 | 2016 | 380020 | 0.090 |
Why?
|
| Logistic Models | 9 | 2015 | 13404 | 0.090 |
Why?
|
| Lipoproteins, LDL | 1 | 2013 | 642 | 0.090 |
Why?
|
| Boston | 5 | 2016 | 9310 | 0.090 |
Why?
|
| Hospital Shared Services | 1 | 2009 | 16 | 0.090 |
Why?
|
| Medical Informatics Applications | 1 | 2011 | 186 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 2 | 2019 | 2715 | 0.090 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2016 | 3655 | 0.090 |
Why?
|
| Middle Aged | 29 | 2016 | 213241 | 0.090 |
Why?
|
| Ethanol | 1 | 2016 | 1343 | 0.090 |
Why?
|
| Limbic System | 1 | 2012 | 424 | 0.090 |
Why?
|
| Humans | 55 | 2023 | 743811 | 0.080 |
Why?
|
| Immunologic Factors | 2 | 2015 | 1580 | 0.080 |
Why?
|
| Lipoproteins | 1 | 2013 | 881 | 0.080 |
Why?
|
| Database Management Systems | 1 | 2010 | 270 | 0.080 |
Why?
|
| Hypothyroidism | 1 | 2013 | 659 | 0.080 |
Why?
|
| Thromboembolism | 1 | 2014 | 987 | 0.080 |
Why?
|
| Delivery, Obstetric | 1 | 2014 | 906 | 0.070 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 2007 | 66 | 0.070 |
Why?
|
| Risk Factors | 16 | 2016 | 72252 | 0.070 |
Why?
|
| Hospital Information Systems | 1 | 2009 | 395 | 0.070 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 5752 | 0.070 |
Why?
|
| Accidental Falls | 1 | 2014 | 1062 | 0.070 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2007 | 163 | 0.070 |
Why?
|
| Autistic Disorder | 1 | 2016 | 1162 | 0.070 |
Why?
|
| Colonoscopy | 1 | 2014 | 1367 | 0.070 |
Why?
|
| Telemedicine | 1 | 2023 | 2874 | 0.070 |
Why?
|
| Medical Informatics | 1 | 2013 | 745 | 0.070 |
Why?
|
| Cesarean Section | 1 | 2014 | 1365 | 0.070 |
Why?
|
| Dyslipidemias | 1 | 2013 | 851 | 0.070 |
Why?
|
| User-Computer Interface | 2 | 2010 | 1431 | 0.070 |
Why?
|
| Hydroxybutyrate Dehydrogenase | 2 | 1996 | 8 | 0.060 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 1937 | 0.060 |
Why?
|
| Genome-Wide Association Study | 4 | 2014 | 12259 | 0.060 |
Why?
|
| ROC Curve | 3 | 2023 | 3527 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 2703 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 1956 | 0.060 |
Why?
|
| Weight Gain | 1 | 2014 | 2294 | 0.060 |
Why?
|
| International Classification of Diseases | 3 | 2018 | 866 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2014 | 3492 | 0.060 |
Why?
|
| Multivariate Analysis | 5 | 2015 | 12243 | 0.060 |
Why?
|
| Genotype | 6 | 2015 | 12944 | 0.060 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 7658 | 0.060 |
Why?
|
| Kidney | 4 | 1991 | 7185 | 0.060 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2010 | 1204 | 0.060 |
Why?
|
| Young Adult | 8 | 2016 | 56392 | 0.060 |
Why?
|
| Apolipoprotein E4 | 1 | 2007 | 668 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2013 | 17439 | 0.060 |
Why?
|
| Case-Control Studies | 7 | 2014 | 21733 | 0.060 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2013 | 2267 | 0.050 |
Why?
|
| Risk Assessment | 5 | 2016 | 23327 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 2281 | 0.050 |
Why?
|
| Aldosterone | 3 | 1991 | 877 | 0.050 |
Why?
|
| Lipids | 1 | 2013 | 3307 | 0.050 |
Why?
|
| Adolescent | 6 | 2016 | 85729 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 3778 | 0.050 |
Why?
|
| Wounds and Injuries | 1 | 2014 | 2401 | 0.050 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2012 | 2305 | 0.050 |
Why?
|
| Health Services Research | 1 | 2009 | 1836 | 0.050 |
Why?
|
| Time Factors | 4 | 2016 | 40038 | 0.050 |
Why?
|
| Comorbidity | 2 | 2013 | 10380 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3255 | 0.050 |
Why?
|
| Follow-Up Studies | 7 | 2016 | 39001 | 0.050 |
Why?
|
| Bipolar Disorder | 2 | 2014 | 5027 | 0.050 |
Why?
|
| Prognosis | 6 | 2016 | 29052 | 0.040 |
Why?
|
| Sodium | 3 | 1982 | 1622 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2013 | 6441 | 0.040 |
Why?
|
| Diuresis | 2 | 1991 | 116 | 0.040 |
Why?
|
| Aged | 14 | 2016 | 163178 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2013 | 3079 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 15526 | 0.040 |
Why?
|
| Prevalence | 2 | 2014 | 15211 | 0.040 |
Why?
|
| Psychiatry | 1 | 2011 | 1694 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2014 | 4599 | 0.040 |
Why?
|
| Incidence | 5 | 2014 | 20948 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2011 | 2210 | 0.040 |
Why?
|
| Models, Biological | 2 | 2013 | 9582 | 0.040 |
Why?
|
| Urine | 3 | 1991 | 370 | 0.040 |
Why?
|
| Genomics | 2 | 2011 | 5714 | 0.040 |
Why?
|
| Risk | 3 | 2015 | 9677 | 0.040 |
Why?
|
| Registries | 1 | 2012 | 8090 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2016 | 40964 | 0.030 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 782 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2023 | 19894 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 6485 | 0.030 |
Why?
|
| Mitochondria, Liver | 1 | 1996 | 187 | 0.030 |
Why?
|
| Blood Volume | 2 | 1991 | 565 | 0.030 |
Why?
|
| Unified Medical Language System | 1 | 2015 | 86 | 0.030 |
Why?
|
| Neoplasms | 2 | 2014 | 21675 | 0.030 |
Why?
|
| Nortriptyline | 1 | 2014 | 81 | 0.030 |
Why?
|
| Phosphatidylcholines | 1 | 1996 | 410 | 0.030 |
Why?
|
| Amitriptyline | 1 | 2014 | 110 | 0.030 |
Why?
|
| Rectal Fistula | 1 | 2014 | 73 | 0.030 |
Why?
|
| United States | 7 | 2019 | 69859 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2018 | 1654 | 0.030 |
Why?
|
| Genetic Research | 1 | 2014 | 174 | 0.030 |
Why?
|
| Research Design | 1 | 2009 | 5983 | 0.030 |
Why?
|
| England | 1 | 2014 | 522 | 0.030 |
Why?
|
| Saimiri | 2 | 1991 | 330 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2007 | 4041 | 0.030 |
Why?
|
| Medical Audit | 1 | 2014 | 466 | 0.030 |
Why?
|
| Potassium | 2 | 1991 | 1336 | 0.030 |
Why?
|
| Pregnancy | 6 | 2016 | 29140 | 0.030 |
Why?
|
| Thyroiditis | 1 | 2013 | 85 | 0.030 |
Why?
|
| Osmolar Concentration | 2 | 1991 | 683 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2012 | 5078 | 0.030 |
Why?
|
| Bupropion | 1 | 2014 | 303 | 0.030 |
Why?
|
| Fornix, Brain | 1 | 2012 | 70 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2015 | 9848 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2012 | 25609 | 0.030 |
Why?
|
| Transglutaminases | 1 | 2013 | 194 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 2013 | 403 | 0.020 |
Why?
|
| Water-Electrolyte Balance | 2 | 1991 | 346 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 1996 | 1524 | 0.020 |
Why?
|
| Citalopram | 1 | 2014 | 403 | 0.020 |
Why?
|
| Natriuresis | 1 | 1991 | 124 | 0.020 |
Why?
|
| Iodide Peroxidase | 1 | 2013 | 293 | 0.020 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 504 | 0.020 |
Why?
|
| Health Insurance Portability and Accountability Act | 1 | 2011 | 99 | 0.020 |
Why?
|
| Sample Size | 1 | 2014 | 841 | 0.020 |
Why?
|
| Child | 3 | 2016 | 77637 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2019 | 2307 | 0.020 |
Why?
|
| Peptides, Cyclic | 1 | 2013 | 400 | 0.020 |
Why?
|
| Mother-Child Relations | 1 | 2014 | 481 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2013 | 15281 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2015 | 789 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1678 | 0.020 |
Why?
|
| Kinetics | 3 | 1996 | 6476 | 0.020 |
Why?
|
| Infant | 1 | 2012 | 35122 | 0.020 |
Why?
|
| Computer Systems | 1 | 2011 | 481 | 0.020 |
Why?
|
| Causality | 1 | 2016 | 1275 | 0.020 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2014 | 576 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 950 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2012 | 675 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2014 | 12354 | 0.020 |
Why?
|
| Anisotropy | 1 | 2012 | 1263 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2013 | 969 | 0.020 |
Why?
|
| Methotrexate | 1 | 2015 | 1726 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 3503 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2012 | 1460 | 0.020 |
Why?
|
| Electronics | 1 | 2009 | 321 | 0.020 |
Why?
|
| Pressure | 1 | 1991 | 1205 | 0.020 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2014 | 868 | 0.020 |
Why?
|
| Disease Progression | 2 | 2014 | 13273 | 0.020 |
Why?
|
| Cross-Sectional Studies | 3 | 2013 | 25032 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 15067 | 0.020 |
Why?
|
| Arginine Vasopressin | 1 | 1987 | 130 | 0.020 |
Why?
|
| Kidney Medulla | 1 | 1987 | 182 | 0.020 |
Why?
|
| Colectomy | 1 | 2012 | 680 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2021 | 7729 | 0.020 |
Why?
|
| Remission Induction | 1 | 2012 | 2384 | 0.020 |
Why?
|
| Creatinine | 1 | 2012 | 1918 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 1789 | 0.020 |
Why?
|
| Goals | 1 | 2011 | 708 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2012 | 957 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2012 | 1091 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2012 | 1531 | 0.020 |
Why?
|
| Brain | 1 | 2012 | 26345 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6487 | 0.020 |
Why?
|
| Vasopressins | 1 | 1987 | 370 | 0.020 |
Why?
|
| Extremities | 1 | 1991 | 867 | 0.020 |
Why?
|
| Peptides | 1 | 2018 | 4406 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 35409 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2014 | 77410 | 0.020 |
Why?
|
| Escherichia coli | 2 | 1996 | 4216 | 0.020 |
Why?
|
| Alleles | 1 | 2015 | 6934 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2011 | 3585 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6539 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2013 | 15518 | 0.010 |
Why?
|
| Rats | 5 | 1996 | 24250 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2019 | 53250 | 0.010 |
Why?
|
| Forecasting | 1 | 2011 | 2950 | 0.010 |
Why?
|
| Kidney Tubules, Distal | 1 | 1982 | 46 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2012 | 6030 | 0.010 |
Why?
|
| Research | 1 | 2010 | 1999 | 0.010 |
Why?
|
| Massachusetts | 1 | 2014 | 8660 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2014 | 6188 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2014 | 3117 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2015 | 6535 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2011 | 2707 | 0.010 |
Why?
|
| Urodynamics | 1 | 1982 | 347 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2012 | 63042 | 0.010 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1982 | 416 | 0.010 |
Why?
|
| Survival Rate | 1 | 2014 | 12786 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8316 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 14714 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2011 | 3587 | 0.010 |
Why?
|
| Cloning, Molecular | 2 | 1996 | 4320 | 0.010 |
Why?
|
| Sex Factors | 1 | 2013 | 10394 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2009 | 2760 | 0.010 |
Why?
|
| Enzyme Activation | 2 | 1996 | 3701 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 1981 | 547 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 57744 | 0.010 |
Why?
|
| Spironolactone | 1 | 1981 | 382 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 3503 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2014 | 12718 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 1996 | 174 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 8939 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 13980 | 0.010 |
Why?
|
| Animals | 7 | 1996 | 168660 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 6976 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1996 | 688 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 1800 | 0.010 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 1993 | 88 | 0.010 |
Why?
|
| Hydroxybutyrates | 1 | 1993 | 82 | 0.010 |
Why?
|
| Depression | 1 | 2013 | 7760 | 0.010 |
Why?
|
| Liposomes | 1 | 1996 | 759 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1996 | 1263 | 0.010 |
Why?
|
| Asthma | 1 | 2009 | 6010 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1980 | 4197 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1993 | 2050 | 0.010 |
Why?
|
| Phospholipids | 1 | 1993 | 784 | 0.010 |
Why?
|
| NAD | 1 | 1993 | 590 | 0.010 |
Why?
|
| Homeostasis | 1 | 1980 | 3337 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1996 | 4009 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 15142 | 0.000 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 1987 | 91 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 6620 | 0.000 |
Why?
|
| Tyrosine | 1 | 1987 | 1462 | 0.000 |
Why?
|
| Gene Expression | 1 | 1993 | 7793 | 0.000 |
Why?
|
| Extracellular Space | 1 | 1980 | 595 | 0.000 |
Why?
|
| Kidney Tubules | 1 | 1980 | 488 | 0.000 |
Why?
|
| Liver | 1 | 1993 | 7479 | 0.000 |
Why?
|
| Regional Blood Flow | 1 | 1980 | 1525 | 0.000 |
Why?
|
| Glomerular Filtration Rate | 1 | 1980 | 2167 | 0.000 |
Why?
|